LION is in a strong uptrend over the past year, with a 1-year price change of +108.98%, significantly outperforming the S&P 500's +21.32%. The current price of $13.96 sits at 83.6% of its 52-week range ($5.65 to $16.70), indicating the stock is near the upper end of its range and reflecting sustained bullish momentum. This positioning near highs suggests the market is pricing in continued positive catalysts, but also carries risk of overextension. Short-term momentum has diverged from the longer-term trend: the 1-month price change is -2.85%, while the 3-month change is +26.11%. This recent pullback from the June high of $16.40 could signal a temporary consolidation or profit-taking after a sharp rally, rather than a trend reversal, given the strong 6-month gain of +46.79%. The stock's beta is not provided, but its 1-year relative strength of +87.66% versus the S&P 500 indicates high volatility and strong outperformance. Key support is at the 52-week low of $5.65, though more immediate support lies near $13.29 (the previous close before the latest trading day). Resistance is at the 52-week high of $16.70; a breakout above this level would signal a continuation of the uptrend, while a breakdown below $13.00 could indicate a deeper correction. The stock's high volatility (1-year change of 109% vs. SPY's 21%) means it is significantly more volatile than the market, requiring careful position sizing.

Revenue has been volatile, with the most recent quarter (Q1 2026) reporting $906.5 million, a 15.3% decline year-over-year from $1.07 billion in Q1 2025. However, the sequential trend shows improvement from the trough of $475.1 million in Q3 2025. The company's two main segments, Motion Picture ($1.62 billion) and Television Production ($1.04 billion), both contribute significantly, but the overall revenue trajectory has been choppy due to the timing of film releases and TV production cycles. The investment case hinges on whether the company can stabilize and grow revenue through its film slate and STARZ platform. Profitability has improved markedly: the company reported net income of $70.2 million in Q1 2026, compared to losses in the prior three quarters (e.g., -$46.2 million in Q4 2025). Gross margin expanded to 42.9% in Q1 2026 from 41.0% in Q4 2025, and operating margin rose to 14.2% from 6.3%. This margin expansion is a positive sign, but the trailing twelve-month net margin remains negative at -7.5%, indicating that sustained profitability is not yet assured. The balance sheet shows a debt-to-equity ratio of -3.11, which is negative due to negative shareholders' equity, a common issue for studios with high intangible assets and debt. Free cash flow was positive $265 million in Q1 2026, a sharp reversal from negative free cash flow in the prior three quarters (e.g., -$111.9 million in Q4 2025). The current ratio of 0.46 indicates tight liquidity, but the operating cash flow of $268.7 million in Q1 2026 provides some cushion. ROE of 15.5% is high, but this is inflated by negative equity; a more meaningful metric is ROA of 1.3% for Q1 2026, which is low but improving.